AEST.MED.INT.HLD.SP.ADR/3 (3FMA) — Free Cash Flow Generation Index
AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Free Cash Flow Generation Index of 0.61x as of December 2024. Free cash flow of €48.88 Million represents 1% of operating cash flow (€79.67 Million). Read 3FMA total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
AEST.MED.INT.HLD.SP.ADR/3 Free Cash Flow Generation Index (2021–2024)
Historical FCF Generation Index trend for AEST.MED.INT.HLD.SP.ADR/3 across 3 annual periods. Explore 3FMA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for AEST.MED.INT.HLD.SP.ADR/3 (2021–2024)
Year-by-year Free Cash Flow Generation Index for AEST.MED.INT.HLD.SP.ADR/3. For the full company profile including market capitalisation, see AEST.MED.INT.HLD.SP.ADR/3 stock valuation.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.61x | €48.88 Million | €79.67 Million | €30.79 Million | ▲ +142.1% |
| 2023 | 0.25x | €18.83 Million | €74.29 Million | €55.46 Million | ▼ -26.6% |
| 2021 | 0.35x | €17.65 Million | €51.09 Million | €33.44 Million | — |